Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
Clinical trial NCT04767698 · TERMINATED
Trial details
- NCT number
- NCT04767698
- Sponsor
- Johns Hopkins University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-05-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.